David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center, shared a post on X:
“At Lung MAP master protocol meeting ‘the three amigos’ ride again. Much accomplished, more to do.
A key to success: flexibility of the Lung MAP platform to evolve as needed to address the rapidly changing diagnostic and the therapeutic landscape of NSCLC.”
More posts featuring Lung MAP.